Concepts (69)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunosuppressive Agents | 3 | 2006 | 248 | 0.240 |
Why?
|
| Cladribine | 1 | 2005 | 3 | 0.220 |
Why?
|
| Cryoglobulinemia | 1 | 2005 | 6 | 0.220 |
Why?
|
| Mycophenolic Acid | 1 | 2005 | 42 | 0.220 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2003 | 6 | 0.190 |
Why?
|
| Lymphoma, T-Cell | 1 | 2003 | 4 | 0.190 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2003 | 10 | 0.190 |
Why?
|
| Stem Cell Transplantation | 1 | 2003 | 221 | 0.170 |
Why?
|
| Hodgkin Disease | 1 | 2000 | 16 | 0.160 |
Why?
|
| Thrombocytopenia | 1 | 2000 | 30 | 0.160 |
Why?
|
| Cyclophosphamide | 3 | 2006 | 37 | 0.150 |
Why?
|
| Radiation Injuries | 1 | 2000 | 85 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2000 | 105 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2000 | 381 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2003 | 443 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2004 | 89 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2005 | 97 | 0.060 |
Why?
|
| Vincristine | 2 | 2003 | 24 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2006 | 62 | 0.060 |
Why?
|
| Adrenal Gland Diseases | 1 | 2005 | 2 | 0.060 |
Why?
|
| Sarcoma, Myeloid | 1 | 2005 | 4 | 0.060 |
Why?
|
| Adrenal Glands | 1 | 2005 | 5 | 0.060 |
Why?
|
| Male | 7 | 2006 | 19441 | 0.060 |
Why?
|
| Trisomy | 1 | 2004 | 11 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2004 | 15 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2004 | 43 | 0.050 |
Why?
|
| Prednisone | 2 | 2003 | 69 | 0.050 |
Why?
|
| Adult | 5 | 2006 | 9259 | 0.050 |
Why?
|
| Middle Aged | 5 | 2006 | 11851 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2003 | 85 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2003 | 76 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2003 | 113 | 0.050 |
Why?
|
| Biopsy | 1 | 2003 | 252 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2004 | 211 | 0.040 |
Why?
|
| Stem Cells | 1 | 2004 | 321 | 0.040 |
Why?
|
| Humans | 7 | 2006 | 32282 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2006 | 3416 | 0.040 |
Why?
|
| Platelet Count | 1 | 2000 | 23 | 0.040 |
Why?
|
| Carmustine | 1 | 2000 | 11 | 0.040 |
Why?
|
| Liver | 1 | 2003 | 492 | 0.040 |
Why?
|
| Etoposide | 1 | 2000 | 38 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2000 | 34 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2000 | 45 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2000 | 86 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2000 | 100 | 0.040 |
Why?
|
| Brain | 1 | 2006 | 965 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 2240 | 0.040 |
Why?
|
| Disease Progression | 1 | 2000 | 591 | 0.030 |
Why?
|
| Adolescent | 2 | 2004 | 3519 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2000 | 3626 | 0.020 |
Why?
|
| Female | 3 | 2006 | 19945 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 717 | 0.020 |
Why?
|
| Neutropenia | 1 | 2006 | 24 | 0.020 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2006 | 29 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2006 | 242 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2005 | 62 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 24 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 26 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 55 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 545 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 114 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1983 | 26 | 0.010 |
Why?
|
| Pain | 1 | 2005 | 304 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 1224 | 0.010 |
Why?
|
| Quality of Life | 1 | 2006 | 964 | 0.010 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1983 | 2 | 0.000 |
Why?
|
| Colony-Forming Units Assay | 1 | 1983 | 16 | 0.000 |
Why?
|
| Leukocytes | 1 | 1983 | 60 | 0.000 |
Why?
|
| Aged | 1 | 1983 | 10263 | 0.000 |
Why?
|